Camber Capital Management’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $7.43M | Hold |
|
|||||
|
2016
Q2 | $8.5M | Hold |
|
|||||
|
2016
Q1 | $11.2M | Hold |
|
|||||
|
2015
Q4 | $13.5M | Buy |
|
|||||
|
2015
Q3 | $8.58M | Hold |
|
|||||
|
2015
Q2 | $14.2M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $3.68M | Hold |
|
|||||
|
2014
Q3 | $4.84M | Hold |
|
|||||
|
2014
Q2 | $7.3M | Hold |
|
|||||
|
2014
Q1 | $9.16M | Hold |
|
|||||
|
2013
Q4 | $7.78M | Buy |
|
|||||
|
2013
Q3 | $8.11M | Buy |
|
|||||
|
2013
Q2 | $7.37M | Buy |
|